TY - JOUR T1 - Impact of exercise training on sarcopenia associated with non-alcoholic fatty liver disease (NAFLD) in humans: A systematic review and meta-analysis JF - medRxiv DO - 10.1101/2020.09.05.20189100 SP - 2020.09.05.20189100 AU - Andrea Gonzalez AU - Mayalen Valero-Breton AU - Camila Huerta-Salgado AU - Oscar Achiardi AU - Felipe Simon AU - Claudio Cabello-Verrugio Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/11/2020.09.05.20189100.abstract N2 - Objective To conduct a systematic review and meta-analyses to assess the efficacy of physical exercise on strength, muscle mass and physical function in adult patients with non-alcoholic fatty liver disease (NAFLD).Design We conducted a systematic review and meta-analysis of seven studies to investigate the effect of exercise training interventions in muscle strength, muscle mass and physical performance.Data sources We identified relevant randomised controlled trials (RCT) in electronic databases (PubMed, CINAHL and Scopus).Eligibility criteria We selected seven RCTs from 66 screened studies. The inclusion criteria were peer-reviewed and English writing articles that included adult patients with liver disease of non-alcoholic origin, applied resistance training, endurance training or both, and assayed at least one variable of sarcopenia.Results Physical performance criterion improved in the exercise groups (mean differences [MD] 8.26 mL/Kg*min [95% CI 5.27 to 11.24 mL/Kg*min], p < 0.0001) versus the control groups; muscle mass, determined as lean body mass (LBM), showed no evidence of the beneficial effects of exercise versus the control groups (MD 1.01 Kg [95% CI −1.78 to 3.80 Kg], p = 0.48); we did not include muscle strength, as none of the selected studies evaluated it.Summary/conclusion Exercise training is a useful intervention strategy to treat sarcopenia in patients with NAFLD; it increases their physical performance in the form of aerobic capacity but does not affect LBM. Future research should include muscle strength assessments and resistance training to evaluate the effects of exercise training on sarcopenia in NAFLD patients.PROSPERO reference number CRD42020191471Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe manuscript was supported by research grants from the National Fund for Science and Technological Development (FONDECYT 1200944 [CC-V], 1201039 [FS]), the Millennium Institute on Immunology and Immunotherapy (P09-016-F [CC-V, FS]) and BASAL Grant-CEDENNA from the National Research and Development Agency (ANID), Government of Chile (AFB180001 [CC-V]). The Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD) is supported by the Iniciativa Científica Milenio (ANID, Chile).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB exemption because we performed a Systematic review and metanalysisAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A ER -